This topic contains a solution. Click here to go to the answer

Author Question: The innovative and marginal sectors will both development responses to a. heightened ... (Read 19 times)

colton

  • Hero Member
  • *****
  • Posts: 627
The innovative and marginal sectors will both development responses to
 
  a. heightened international competition and technological change.
  b. reduced productivity and lower efficiency.
  c. higher wages and greater job security.
  d. skill levels of workers and the number of unemployed workers.
  e. job retraining programs and the demand for increased leisure.

Question 2

Workers' power to affect change is based on their:
 
  a. voting patterns.
  b. knowledge of technology and products and collective organizations.
  c. ability to gain positions as shareholders in their companies.
  d. willingness to relocate to new plants in distant cities.
  e. level of education and desire to get ahead.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

upturnedfurball

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

a

Answer to Question 2

b





 

Did you know?

The most common childhood diseases include croup, chickenpox, ear infections, flu, pneumonia, ringworm, respiratory syncytial virus, scabies, head lice, and asthma.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Historic treatments for rheumatoid arthritis have included gold salts, acupuncture, a diet consisting of apples or rhubarb, nutmeg, nettles, bee venom, bracelets made of copper, prayer, rest, tooth extractions, fasting, honey, vitamins, insulin, snow collected on Christmas, magnets, and electric convulsion therapy.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library